Context: The number of young Koreans using antidepressants and antianxiety medications is increasing.

Objective: Studies evaluating the association between these medications and weight gain are limited. We investigated this association among Korean young adults.

Methods: We included 792,022 participants aged 19-39 years who underwent Korean National Health Insurance Service health examinations more than twice between 2009 and 2019. Multivariate logistic regression analysis was performed to evaluate the association between antidepressants and antianxiety medications and weight gain.

Results: The participants' average age and body mass index were 29.4±4.7 years and 23.0±3.6 kg/m2, respectively. The proportions of weight gain ≥10 kg/year were 1.7%; 2.4%; 2.9%; and 4.1% in individuals using neither antidepressants nor antianxiety medications; only antianxiety medications; only antidepressants; and both antidepressants and antianxiety medications, respectively. Compared with individuals using neither antidepressants nor antianxiety medications, the rate ratios (95% confidence intervals) for weight gain ≥10 kg/year were higher in those using only antianxiety medications; only antidepressants; and both antidepressants and antianxiety medications; at 1.77 (1.69-1.85); 2.15 (2.05-2.0); and 3.04 (2.91-3.18), respectively.

Conclusions: Using antidepressants and antianxiety medications may contribute to an increased risk of weight gain among Korean young adults. The potential risk for weight gain should be considered when those medications are used and the prevention of weight gain is needed.

Download full-text PDF

Source
http://dx.doi.org/10.1210/clinem/dgae513DOI Listing

Publication Analysis

Top Keywords

antianxiety medications
40
antidepressants antianxiety
32
weight gain
28
medications
12
medications weight
12
antianxiety
10
antidepressants
9
association antidepressants
8
weight
8
gain korean
8

Similar Publications

L. oligo-polysaccharides (CIOs), obtained from L., is a mixture of oligosaccharides and polysaccharides.

View Article and Find Full Text PDF

The sodium-dependent membrane transporter SLC6A15 (BAT2) belongs to the SLC6 family, which comprises carriers of amino acids and monoamines. BAT2 is expressed in the central nervous system (CNS), including the glutaminergic and GABAergic system. SLC6A15 supplies neurons with neutral amino acids.

View Article and Find Full Text PDF

[Research progress on "homologous different effects" of Aurantii Fructus Immaturus and Aurantii Fructus].

Zhongguo Zhong Yao Za Zhi

October 2024

School of Pharmacy, Hunan University of Chinese Medicine Changsha 410208, China Key Laboratory of Druggability and Preparation Modification for Traditional Chinese Medicine of Hunan Province Changsha 410208, China Supramolecular Mechanism and Mathematic-Physics Characterization for Chinese Materia Medicine, Hunan University of Chinese Medicine Changsha 410208, China.

Aurantii Fructus Immaturus and Aurantii Fructus are the dried young and immature fruits of Rutaceae, which mainly originate from the same part of lime. They are harvested from the same part with different maturity levels, which leads to different medicinal materials. It has been reported that Aurantii Fructus Immaturus and Aurantii Fructus contain flavonoids, alkaloids, volatile oils, coumarins and other components, which have a variety of pharmacological effects such as gastrointestinal disorder-alleviating, anti-anxiety, lipid metabolism-modulating, anti-inflammatory, antimicrobial, and antioxidant effects.

View Article and Find Full Text PDF

Background: standardised extracts, characterised by the presence of hydroxycinnamic acids, have been experimentally demonstrated to be endowed with anti-anxiety and anti-insomnia pharmacological actions. These effects, probably attributable, at least in part, to the role played by rosmarinic acid on GABA-T, have not always been observed in a reproducible manner in humans, perhaps due to the poor bioavailability of these compounds.

Methods: as nutraceuticals and botanicals could be an alternative option to prescription medications for alleviating symptoms of mild anxiety and insomnia, we have verified in a prospective, double-blind, placebo-controlled, and cross-over study the supporting role on sleep quality played by a highly standardised extract, formulated as Phytosome™ (MOP) to improve the oral bioavailability of its active polyphenolic components.

View Article and Find Full Text PDF

Background: Pain management for knee osteoarthritis (KOA) patients is challenging. Pain arises from both physiological and psychological interactions, with anxiety and depression potentially contributing as risk factors that hinder effective pain management in KOA patients.

Methods: Before treatment(T1), A total of 206 elderly inpatients with KOA were enrolled based on initial screening criteria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!